Clinical and Metabolic Factors Associated With Liver Fibrosis Risk (Fib-4 >1.3) in Patients With Rheumatoid Arthritis
Litsenziya: cc-by
Annotatsiya
General Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with extra-articular manifestations, including liver involvement. Specific Background: Liver fibrosis in RA may result from the interaction of inflammatory and metabolic factors. Knowledge Gap: Evidence on clinical and metabolic predictors of liver fibrosis risk in RA remains limited. Aims: This study aimed to identify factors associated with increased liver fibrosis risk (FIB-4 >1.3) in patients with rheumatoid arthritis. Methods: A cross-sectional study was conducted among 156 patients with RA. Clinical, laboratory, and metabolic parameters were analyzed using comparative, correlation, and logistic regression analyses. Results: Elevated FIB-4 was observed in 34.6% of patients. Older age, higher body mass index, elevated aspartate aminotransferase levels, diabetes mellitus, and longer disease duration were significantly associated with increased fibrosis risk and were identified as independent predictors. Novelty: The study highlights the combined role of demographic, metabolic, and biochemical factors in liver fibrosis risk among RA patients. Implications: FIB-4 may serve as a practical non-invasive screening tool to identify patients requiring closer hepatic evaluation and metabolic assessment. Highlights: • Approximately one-third of patients with rheumatoid arthritis exhibited elevated liver fibrosis risk based on FIB-4 assessment.• Older age, higher aspartate aminotransferase levels, greater body mass index, diabetes mellitus, and longer disease duration were independently associated with increased fibrosis risk.• Non-invasive fibrosis screening supports early recognition of hepatic involvement within routine rheumatology practice. Keywords: Rheumatoid Arthritis, Liver Fibrosis, Fibrosis-4 Index, Metabolic Factors, Diabetes Mellitus
Hali tarjima qilinmagan